{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T16:06:49Z","timestamp":1725552409948},"reference-count":17,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780123742032"}],"license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010]]},"DOI":"10.1016\/b978-0-12-374203-2.00128-7","type":"book-chapter","created":{"date-parts":[[2010,4,21]],"date-time":"2010-04-21T08:54:50Z","timestamp":1271840090000},"page":"52-59","source":"Crossref","is-referenced-by-count":2,"title":["Molecular Mechanisms of Angiostasis"],"prefix":"10.1016","author":[{"given":"A.","family":"Sudhakar","sequence":"first","affiliation":[]},{"given":"R.","family":"Kalluri","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/B978-0-12-374203-2.00128-7_bib0005","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1182\/blood-2007-01-066282","article-title":"Regulation of COX-2 mediated signaling by \u03b13 type IV noncollagenous domain in tumor angiogenesis","volume":"110","author":"Boosani","year":"2007","journal-title":"Blood Journal"},{"year":"2002","series-title":"Tumor Angiogenesis. Part II Scientific Foundation, Section 1: Cancer Biology. Cancer Medicine","author":"Folkman","key":"10.1016\/B978-0-12-374203-2.00128-7_bib0010"},{"key":"10.1016\/B978-0-12-374203-2.00128-7_bib0015","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1535-6108(03)00133-8","article-title":"Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin","volume":"3","author":"Hamano","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/B978-0-12-374203-2.00128-7_bib0020","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1101\/sqb.2002.67.255","article-title":"Discovery of type IV collagen non-collagenous domains as novel integrin ligands and endogenous inhibitors of angiogenesis","volume":"67","author":"Kalluri","year":"2002","journal-title":"Cold Spring Harbor Symposia on Quantitative Biology"},{"key":"10.1016\/B978-0-12-374203-2.00128-7_bib0025","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/nrc1094","article-title":"Basement membranes: Structure, assembly and role in tumour angiogenesis","volume":"3","author":"Kalluri","year":"2003","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/B978-0-12-374203-2.00128-7_bib0030","doi-asserted-by":"crossref","first-page":"21340","DOI":"10.1074\/jbc.M001956200","article-title":"Distinct anti-tumor properties of a type IV collagen domain derived from basement membrane","volume":"275","author":"Maeshima","year":"2000","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/B978-0-12-374203-2.00128-7_bib0035","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1126\/science.1065298","article-title":"Tumstatin, an endothelial cell-specific inhibitor of protein synthesis","volume":"295","author":"Maeshima","year":"2002","journal-title":"Science"},{"key":"10.1016\/B978-0-12-374203-2.00128-7_bib0040","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1158\/0008-5472.CAN-04-3536","article-title":"Canstatin acts on endothelial and tumor cells via mitochondrial damage initiated through interaction with \u03b1V\u03b23 and \u03b1V\u03b25 integrins","volume":"65","author":"Magnon","year":"2005","journal-title":"Cancer Research"},{"key":"10.1016\/B978-0-12-374203-2.00128-7_bib0045","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/ijc.23269","article-title":"Type IV collagen alpha6 chain-derived noncollagenous domain 1 (\u03b16(IV)NC1) inhibits angiogenesis and tumor growth","volume":"122","author":"Mundel","year":"2008","journal-title":"International Journal of Cancer"},{"key":"10.1016\/B978-0-12-374203-2.00128-7_bib0050","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1158\/0008-5472.CAN-04-2427","article-title":"Endogenous inhibitors of angiogenesis","volume":"65","author":"Nyberg","year":"2005","journal-title":"Cancer Research"},{"issue":"18","key":"10.1016\/B978-0-12-374203-2.00128-7_bib0055","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1016\/j.yexcr.2008.08.011","article-title":"Characterization of the anti-angiogenic properties of arresten, an alpha1beta1 integrin-dependent collagen-derived tumor suppressor","volume":"314","author":"Nyberg","year":"2008","journal-title":"Experimental Cell Research"},{"key":"10.1016\/B978-0-12-374203-2.00128-7_bib0060","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.1074\/jbc.275.11.8051","article-title":"New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo","volume":"275","author":"Petitclerc","year":"2000","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/B978-0-12-374203-2.00128-7_bib0065","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jcp.20645","article-title":"Recombinant non-collagenous domain of \u03b12(IV) collagen causes involution of choroidal neovascularization by inducing apoptosis","volume":"208","author":"Silva","year":"2006","journal-title":"Journal of Cellular Physiology"},{"key":"10.1016\/B978-0-12-374203-2.00128-7_bib0070","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4137\/GRSB.S345","article-title":"Signaling mechanisms of endogenous angiogenesis inhibitors derived from type IV collagen","volume":"1","author":"Sudhakar","year":"2007","journal-title":"Gene Regulation and System Biology"},{"key":"10.1016\/B978-0-12-374203-2.00128-7_bib0075","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1007\/s11095-008-9634-z","article-title":"Inhibition of tumor angiogenesis by tumstatin: Insights into signaling mechanisms and implications in cancer regression","volume":"12","author":"Sudhakar","year":"2008","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/B978-0-12-374203-2.00128-7_bib0080","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1172\/JCI24813","article-title":"Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin","volume":"115","author":"Sudhakar","year":"2005","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/B978-0-12-374203-2.00128-7_bib0085","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1006\/dbio.1994.1176","article-title":"Hydra cell aggregate development is blocked by selective fragment of fibronectin and type IV collagen","volume":"164","author":"Zhang","year":"1994","journal-title":"Developmental Biology"}],"container-title":["Encyclopedia of the Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780123742032001287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780123742032001287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T22:31:43Z","timestamp":1591223503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780123742032001287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"ISBN":["9780123742032"],"references-count":17,"URL":"https:\/\/doi.org\/10.1016\/b978-0-12-374203-2.00128-7","relation":{},"subject":[],"published":{"date-parts":[[2010]]}}}